Lv2
118 积分 2022-11-21 加入
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer
1天前
待确认
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study
9天前
已关闭
Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trial
9天前
已完结
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
10天前
已完结
Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China
11天前
已完结
The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer
11天前
已完结
PI3K Inhibitors in Breast Cancer Therapy
11天前
已完结
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
11天前
已完结
Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer
11天前
已完结
Upregulation of Trop-2 quantitatively stimulates human cancer growth
11天前
已完结
皖公网安备34019202002308
